Intravenous High-Dose Vitamin C in Cancer Therapy

An NCI-affiliated laboratory's explainer on the history and current status of high-dose vitamin C in cancer therapy. Byline (Lewis Cantley and Jihye Yun) and publication date (24 January 2020) confirmed by direct fetch of the page. Summarizes the Cameron-Pauling 1976/1978 PNAS studies' retrospective, non-placebo-controlled design; contrasts it with the Mayo Clinic's randomized double-blind trials and the two studies' differing treatment durations and administration routes; and states plainly that because the Mayo trials were more rigorous, 'people trusted the Mayo Clinic's data and discredited the Cameron-Pauling trials, dampening the enthusiasm for vitamin C as a cancer therapy.'